[{"address1": "200 Arsenal Yards Boulevard", "address2": "Suite 230", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "857 285 5300", "website": "https://www.kymeratx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 188, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bruce L. Booth DPHIL, Ph.D.", "age": 50, "title": "Co-Founder & Independent Chairman", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 75000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nello  Mainolfi M.D., Ph.D.", "age": 45, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1075600, "exercisedValue": 457971, "unexercisedValue": 20455824}, {"maxAge": 1, "name": "Mr. Bruce N. Jacobs CFA", "title": "Chief Financial Officer", "fiscalYear": 2023, "totalPay": 671200, "exercisedValue": 249766, "unexercisedValue": 5641756}, {"maxAge": 1, "name": "Dr. Jeremy G. Chadwick Ph.D.", "age": 61, "title": "Chief Operating Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 614498, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ellen V. Chiniara Esq., J.D.", "age": 65, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 640345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jared A. Gollob M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 723600, "exercisedValue": 0, "unexercisedValue": 4995031}, {"maxAge": 1, "name": "Ms. Karen  Weisbach", "title": "Head of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juliet  Williams B.A Ph.D.", "title": "Head of Research", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 32.54, "open": 32.39, "dayLow": 31.75, "dayHigh": 33.5599, "regularMarketPreviousClose": 32.54, "regularMarketOpen": 32.39, "regularMarketDayLow": 31.75, "regularMarketDayHigh": 33.5599, "payoutRatio": 0.0, "beta": 2.227, "forwardPE": -10.5755625, "volume": 639571, "regularMarketVolume": 639571, "averageVolume": 560201, "averageVolume10days": 885690, "averageDailyVolume10Day": 885690, "bid": 23.71, "ask": 40.89, "bidSize": 2, "askSize": 2, "marketCap": 2136011392, "fiftyTwoWeekLow": 29.07, "fiftyTwoWeekHigh": 53.27, "priceToSalesTrailing12Months": 45.377537, "fiftyDayAverage": 38.3554, "twoHundredDayAverage": 41.52405, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1735029632, "profitMargins": 0.0, "floatShares": 42841049, "sharesOutstanding": 64944100, "sharesShort": 7339095, "sharesShortPriorMonth": 8352487, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.11310001, "heldPercentInsiders": 0.02491, "heldPercentInstitutions": 1.09988, "shortRatio": 14.41, "shortPercentOfFloat": 0.1263, "impliedSharesOutstanding": 64944100, "bookValue": 12.877, "priceToBook": 2.5541663, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -223858000, "trailingEps": -2.98, "forwardEps": -3.11, "enterpriseToRevenue": 36.859, "enterpriseToEbitda": -6.92, "52WeekChange": -0.23055094, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 32.89, "targetHighPrice": 97.0, "targetLowPrice": 41.0, "targetMeanPrice": 58.27778, "targetMedianPrice": 56.5, "recommendationMean": 1.47368, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 18, "totalCash": 488744000, "totalCashPerShare": 7.526, "ebitda": -250736992, "totalDebt": 87761000, "quickRatio": 7.226, "currentRatio": 7.53, "totalRevenue": 47072000, "debtToEquity": 10.503, "revenuePerShare": 0.627, "returnOnAssets": -0.20652, "returnOnEquity": -0.36382, "grossProfits": -193176000, "freeCashflow": -126831376, "operatingCashflow": -194500992, "revenueGrowth": -0.846, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -10.921689, "financialCurrency": "USD", "symbol": "KYMR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1741382400, "regularMarketTime": 1741381201, "regularMarketChangePercent": 1.0755945, "regularMarketPrice": 32.89, "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_542085131", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Kymera Therapeutics, Inc.", "longName": "Kymera Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1598016600000, "postMarketChangePercent": 0.0, "postMarketPrice": 32.89, "postMarketChange": 0.0, "regularMarketChange": 0.34999847, "regularMarketDayRange": "31.75 - 33.5599", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 560201, "fiftyTwoWeekLowChange": 3.8199997, "fiftyTwoWeekLowChangePercent": 0.13140693, "fiftyTwoWeekRange": "29.07 - 53.27", "fiftyTwoWeekHighChange": -20.380001, "fiftyTwoWeekHighChangePercent": -0.38257933, "fiftyTwoWeekChangePercent": -23.055094, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746016200, "earningsTimestampEnd": 1746448200, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.98, "epsForward": -3.11, "epsCurrentYear": -3.69631, "priceEpsCurrentYear": -8.898063, "fiftyDayAverageChange": -5.4654007, "fiftyDayAverageChangePercent": -0.14249365, "twoHundredDayAverageChange": -8.634052, "twoHundredDayAverageChangePercent": -0.20792894, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-08-21", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Kymera Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]